Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PG5N
|
|||
| Drug Name |
PMID25991433-Compound-J1
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
DANA-FARBER CANCER INSTITUTE, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H29N7O2
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C=CCN(C)C)NC3=NC=CC(=N3)C4=CN=CC=C4
|
|||
| InChI |
1S/C29H29N7O2/c1-20-8-11-24(18-26(20)35-29-31-16-14-25(34-29)22-6-4-15-30-19-22)33-28(38)21-9-12-23(13-10-21)32-27(37)7-5-17-36(2)3/h4-16,18-19H,17H2,1-3H3,(H,32,37)(H,33,38)(H,31,34,35)/b7-5+
|
|||
| InChIKey |
YFRXAAWSVLQGDR-FNORWQNLSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mitogen-activated protein kinase (MAPK) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Mitogen-activated protein kinase (MAPK) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.